Stockreport

Coloplast A/S - Interim Financial Report, Q1 2023/24 [Yahoo! Finance]

COLOPLAST AS SP/ADR  (CLPBY) 
NASDAQ:AMEX Investor Relations: coloplast.com/investor-relations
PDF Coloplast delivered a solid Q1 with 8% organic growth and an EBIT margin of 28%. Reported revenue in DKK grew 8% with 4%-points contribution from Kerecis (underlying gr [Read more]